However, to benefit from the treatment, optimal patient adherence to medication is crucial. Anticoagulation is highly effective for stroke prevention in AF. This does not alter our adherence to PLOS ONE policies on sharing data and materials.Ītrial fibrillation (AF) patients are at increased risk of stroke and often require long-term preventive treatment with anticoagulants. CM is an employee of Evidera, a consultancy company that has received consultancy fees from Janssen Scientific Affairs, LLC. FL, GG, WW, and PL are employees of Groupe d’analyse, Ltée., a consulting company that has received research grants from Janssen Scientific Affairs. CM is an employee of Evidera, a consultancy company that has received consultancy fees from Janssen Scientific Affairs, LLC.Ĭompeting interests: CC is an employee of Janssen Scientific Affairs. FL, GG, WW, and PL are employees of Groupe d’analyse, Ltée, a consulting company that has received research grants from Janssen Scientific Affairs. CC is an employee of Janssen Scientific Affairs. The funders were involved in the study design, data collection, analysis, decision to publish, and preparation of the manuscript. Access to this data set is available to other interested parties for a fee set by Truven Health Analytics ( ).įunding: This research was funded by Janssen Scientific Affairs, LLC, Raritan, NJ, United States ( ). Janssen purchased access to the Truven MarketScan Database (on a contract per-project use). The claims database (Truven Health Analytics MarketScan ® Databases) is provided by a third-party vendor. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: This study used claims data to analyze adherence to rivaroxaban and apixaban. Received: JAccepted: FebruPublished: April 5, 2018Ĭopyright: © 2018 McHorney et al. PLoS ONE 13(4):Įditor: Hugo ten Cate, Maastricht University Medical Center, NETHERLANDS Citation: McHorney CA, Crivera C, Laliberté F, Germain G, Wynant W, Lefebvre P (2018) Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2023
Categories |